Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 27;18(1):219.
doi: 10.1186/s13023-023-02795-2.

European Achondroplasia Forum guiding principles for the detection and management of foramen magnum stenosis

Affiliations

European Achondroplasia Forum guiding principles for the detection and management of foramen magnum stenosis

Melita Irving et al. Orphanet J Rare Dis. .

Abstract

Foramen magnum stenosis is a serious, and potentially life-threatening complication of achondroplasia. The foramen magnum is smaller in infants with achondroplasia, compared with the general population, and both restricted growth in the first 2 years and premature closure of skull plate synchondroses can contribute to narrowing. Narrowing of the foramen magnum can lead to compression of the brainstem and spinal cord, and result in sleep apnoea and sudden death. There is a lack of clarity in the literature on the timing of regular monitoring for foramen magnum stenosis, which assessments should be carried out and when regular screening should be ceased. The European Achondroplasia Forum (EAF) is a group of clinicians and patient advocates, representative of the achondroplasia community. Members of the EAF Steering Committee were invited to submit suggestions for guiding principles for the detection and management of foramen magnum stenosis, which were collated and discussed at an open workshop. Each principle was scrutinised for content and wording, and anonymous voting held to pass the principle and vote on the level of agreement. A total of six guiding principles were developed which incorporate routine clinical monitoring of infants and young children, timing of routine MRI screening, referral of suspected foramen magnum stenosis to a neurosurgeon, the combination of assessments to inform the decision to decompress the foramen magnum, joint decision making to proceed with decompression, and management of older children in whom previously undetected foramen magnum stenosis is identified. All principles achieved the ≥ 75% majority needed to pass (range 89-100%), with high levels of agreement (range 7.6-8.9). By developing guiding principles for the detection and management of foramen magnum stenosis, the EAF aim to enable infants and young children to receive optimal monitoring for this potentially life-threatening complication.

Keywords: Achondroplasia; Detection; European Achondroplasia Forum; Foramen Magnum Stenosis; Guiding principles; Management; Recommendations.

PubMed Disclaimer

Conflict of interest statement

MAS, VCD, SF, HHK, CL, PK, TBO have no conflict of interest to declare. PA has received honoraria or consultation fees from BioMarin and support as a local principal investigator in achondroplasia clinical trials from BioMarin, Pfizer and QED. GB has received honoraria or consultation fees from BioMarin and funding from Ascendis for clinical trials. SB received honoraria or consultation fees from BioMarin. EGN has received honoraria or consultation fees from BioMarin. MI has received honoraria or consultation fees from Alexion, Ascendis Pharma, BioMarin, Innoskel, Ipsen, Kyowa Kirin, Novo Nordisk, QED Therapeutics, Sanofi and Theracon/Pfizer. MM has received grants/research support from Pfizer, Novo Nordisk and Merck, and honoraria or consultation fees from Pfizer, Novo Nordisk, Sandoz and BioMarin. KM has received grants/research support from BioMarin and honoraria or consultation fees from BioMarin and QED. GM has received honoraria or consultation fees from BioMarin, Ipsen and Pfizer. SS received honoraria or consultation fees from BioMarin Ascendis, Kyowa Kirin.

Figures

Fig. 1
Fig. 1
A case of an asymptomatic infant with achondroplasia a) as a newborn and b) at 4 months with neurological signs, foramen magnum stenosis and spinal cord compression, Fornarino Grade 3 [5]

References

    1. Coi A, Santoro M, Garne E, Pierini A, Addor M-C, Alessandri J-L, et al. Epidemiology of achondroplasia: a population-based study in Europe. Am J Med Genet Part A. 2019;179:1–8. - PubMed
    1. Pauli RM. Achondroplasia: a comprehensive clinical review. Orphanet J Rare Dis. 2019;14:1–19. doi: 10.1186/s13023-018-0972-6. - DOI - PMC - PubMed
    1. Wright MJ, Irving MD. Clinical management of achondroplasia. Arch Dis Child. 2012;97:129–34. doi: 10.1136/adc.2010.189092. - DOI - PubMed
    1. White KK, Bompadre V, Goldberg MJ, Bober MB, Campbell JW, Cho T-J, et al. Best practices in the evaluation and treatment of foramen magnum stenosis in achondroplasia during infancy. Am J Med Genet A. 2016;170A:42–51. doi: 10.1002/ajmg.a.37394. - DOI - PubMed
    1. Fornarino S, Rossi DP, Severino M, Pistorio A, Allegri AEM, Martelli S, et al. Early impairment of somatosensory evoked potentials in very young children with achondroplasia with foramen magnum stenosis. Dev Med Child Neurol. 2017;59:192–8. doi: 10.1111/dmcn.13243. - DOI - PubMed

Publication types